EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Predicting cardiovascular disease risk from gut microbial genes

Jan Claesen iD, J Mark Brown iD

mBio · 2023

DOI: 10.1128/mbio.01970-23 ↗

Kurz gefasst

Kommentar in der Zeitschrift mBio, 2023. Verfasst von Jan Claesen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Cardiovascular Diseases, Methylamines, Bacteria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut bacteria-driven production of trimethylamine (TMA) is strongly associated with cardiovascular disease. Borton et al. (mBio 14:e01511-23, 2023, https://doi.org/10.1128/mbio.01511-23 ) introduce the Methylated Amine Gene Inventory of Catabolism database (MAGICdb), comprehensively cataloging pathways involved in TMA metabolism. By integrating transcriptomics, proteomics, and metagenomic data, this work identifies key bacterial players in the process and can link gut microbial gene content to fecal TMA concentrations. This work shows that methylated amine metabolism is a keystone microbiome process carried out by a small proportion of the community. Proatherogenic pathways are more widely distributed among the gut microbiota, and new TMA-reducing genera were identified that might offer new potential for probiotic strategies or targeted microbiome interventions. Remarkably, MAGICdb’s power to predict cardiovascular disease risk matches an approach using more traditional lipid risk factors. This open source will be a valuable tool for the community to link methylated amine metabolism to gut microbiome-related human health conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCardiovascular DiseasesMethylaminesBacteriaHumansFecesMetagenomicsRisk Factors

Stichwörter der Autor:innen

cardiovascular diseasemetabolismmicrobiome

Substanzen

Methylaminestrimethylamine

Autor:innen und Institutionen

  • Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
  • Center for Microbiome and Human Health, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Cancer Biology, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Jan Claesen, J Mark Brown

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIAAA NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • HHS | NIH | NIAID | Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Institute on Alcohol Abuse and Alcoholism
  • HHS | NIH | National Heart, Lung, and Blood Institute

Zitieren

APA

Claesen, J., & Brown, J. M. (2023). Predicting cardiovascular disease risk from gut microbial genes. mBio. https://doi.org/10.1128/mbio.01970-23

Vancouver

Claesen J, Brown JM. Predicting cardiovascular disease risk from gut microbial genes. mBio. 2023. doi:10.1128/mbio.01970-23

BibTeX
@article{Claesen2023,
  author = {Claesen, Jan and Brown, J Mark},
  title = {Predicting cardiovascular disease risk from gut microbial genes},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.01970-23}
}
Kostenlos starten →